Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Investigators at Johns Hopkins University release new data on cancer vaccines
September 2nd, 2008
" To examine the efficacy of adjuvant chemoradiotherapy after pancreaticoduodenectomy (PD) for pancreatic adenocarcinoma (PC) in patients undergoing resection at Johns Hopkins Hospital (JHH; Baltimore, MD). Patients and Methods Between August 30, 1993, and February 28, 2005, a total of 908 patients underwent PD for PC at JHH," researchers in the United States report. "A prospective database was reviewed to determine which patients received fluorouracil (FU)-based CRT. Excluded patients had metastatic disease, died 60 or fewer days after PD, received preoperative therapy, an experimental vaccine, adjuvant chemotherapy or radiation alone. The final cohort includes 616...
Source: Cancer Weekly (2008-09-02)
|
